Related Experiment Video
Updated: Jun 3, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
[Risk stratification tools for evaluating thromboembolic risk in atrial fibrillation]
Yasmina Ouardiri1, Christophe Marti, Sebastian Carballo
1Service de médecine interne générale, Département de médecine interne, HUG, 1211 Genève 14. yasmina.ouardiri@hcuge.ch
Abstract:
New European recommendations on management of stroke prevention in atrial fibrillation have been published. They introduce a new risk stratification score called CHA2DS2VASc, which may allow for better thromboembolic risk discrimination amongst low risk patients. We review stroke risk stratification in atrial fibrillation, limitations of available scores and discuss the practical implications of the new recommendations.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Dysrhythmias V: Evaluating Dysrhythmias
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

